Does INSULIN GLARGINE Cause Product communication issue? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Product communication issue have been filed in association with INSULIN GLARGINE (Lantus Solostar). This represents 0.0% of all adverse event reports for INSULIN GLARGINE.
22
Reports of Product communication issue with INSULIN GLARGINE
0.0%
of all INSULIN GLARGINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product communication issue From INSULIN GLARGINE?
Of the 22 reports.
Is Product communication issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INSULIN GLARGINE. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does INSULIN GLARGINE Cause?
Blood glucose increased (19,234)
Inappropriate schedule of product administration (8,982)
Product storage error (7,743)
Off label use (6,842)
Visual impairment (5,793)
Blood glucose decreased (4,552)
Drug ineffective (4,351)
Hypoglycaemia (4,212)
Injection site pain (3,574)
Device issue (3,175)
What Other Drugs Cause Product communication issue?
EVOLOCUMAB (2,341)
SEMAGLUTIDE (842)
ERENUMAB-AOOE (598)
SOMATROPIN (350)
PEGFILGRASTIM (333)
ETANERCEPT (122)
ALBUTEROL (121)
NIRMATRELVIR\RITONAVIR (70)
DENOSUMAB (68)
LEVODOPA (61)
Which INSULIN GLARGINE Alternatives Have Lower Product communication issue Risk?
INSULIN GLARGINE vs INSULIN GLARGINE-YFGN
INSULIN GLARGINE vs INSULIN GLARGINE\LIXISENATIDE
INSULIN GLARGINE vs INSULIN GLULISINE
INSULIN GLARGINE vs INSULIN HUMAN
INSULIN GLARGINE vs INSULIN LISPRO